000 | 01541 a2200433 4500 | ||
---|---|---|---|
005 | 20250514043114.0 | ||
264 | 0 | _c20030123 | |
008 | 200301s 0 0 eng d | ||
022 | _a0392-2936 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSajdak, S | |
245 | 0 | 0 |
_aBleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII. _h[electronic resource] |
260 |
_bEuropean journal of gynaecological oncology _c2002 |
||
300 |
_a325-6 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 |
_aAdenocarcinoma _xcomplications |
650 | 0 | 4 | _aAdministration, Intravaginal |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aEndometrial Neoplasms _xcomplications |
650 | 0 | 4 |
_aEthamsylate _xadministration & dosage |
650 | 0 | 4 |
_aFactor VII Deficiency _xcomplications |
650 | 0 | 4 |
_aFactor VIIa _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHemostatics _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 |
_aMandibular Neoplasms _xcomplications |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 | _aNeoplasm Recurrence, Local |
650 | 0 | 4 | _aRecombinant Proteins |
650 | 0 | 4 |
_aSarcoma _xcomplications |
650 | 0 | 4 |
_aTranexamic Acid _xadministration & dosage |
650 | 0 | 4 |
_aUterine Hemorrhage _xdrug therapy |
650 | 0 | 4 |
_aVaginal Neoplasms _xcomplications |
700 | 1 | _aMoszynski, R | |
700 | 1 | _aOpala, T | |
773 | 0 |
_tEuropean journal of gynaecological oncology _gvol. 23 _gno. 4 _gp. 325-6 |
|
999 |
_c12095436 _d12095436 |